Immunity against cancer: lessons learned from melanoma
AN Houghton, JS Gold, NE Blachere - Current opinion in immunology, 2001 - Elsevier
AN Houghton, JS Gold, NE Blachere
Current opinion in immunology, 2001•ElsevierMost major advances in human cancer immunology and immunotherapy have come from
studies in melanoma. We are beginning to understand the immune repertoire of T cells and
antibodies that are active against melanoma, with recent glimpses of the CD4+ T cell
repertoire. The view of what the immune system can see is extending to mutations and parts
of the genome that are normally invisible.
studies in melanoma. We are beginning to understand the immune repertoire of T cells and
antibodies that are active against melanoma, with recent glimpses of the CD4+ T cell
repertoire. The view of what the immune system can see is extending to mutations and parts
of the genome that are normally invisible.
Most major advances in human cancer immunology and immunotherapy have come from studies in melanoma. We are beginning to understand the immune repertoire of T cells and antibodies that are active against melanoma, with recent glimpses of the CD4+ T cell repertoire. The view of what the immune system can see is extending to mutations and parts of the genome that are normally invisible.
Elsevier